40 results
8-K
EX-99.1
DAWN
Day One Biopharmaceuticals Inc
6 May 24
Day One Reports First Quarter 2024 Financial Results and Corporate Progress
4:30pm
are grateful to the members of the pediatric brain tumor community whose support of the program has been invaluable,” said Jeremy Bender, Ph.D., chief
8-K
EX-99.1
DAWN
Day One Biopharmaceuticals Inc
24 Apr 24
Regulation FD Disclosure
8:01am
this serious and life-threatening disease of childhood and adolescence. We are grateful to the pLGG community, including patients and their families … , but also for the broader pediatric brain tumor community. Thanks to the close collaboration between RAPNO and Response Assessment for Neuro-Oncology (RANO
8-K
EX-99.1
09y39tfls ywt
17 Jan 24
Day One Announces Two New Appointments to Board of Directors
8:25am
8-K
EX-14.1
2uapaiqhbd pjf
8 Dec 23
Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics
4:05pm
424B5
kdaipyl6cido mat
7 Jun 23
Prospectus supplement for primary offering
4:57pm
424B5
807k90qa5nrm6cfysa4j
6 Jun 23
Prospectus supplement for primary offering
4:21pm
PRE 14A
ivlptx
18 Apr 23
Preliminary proxy
4:05pm
8-K
EX-99.2
4aj9yt
7 Nov 22
Day One Reports Third Quarter 2022 Financial Results and Corporate Progress
4:31pm
8-K
EX-99.2
3f777
12 Sep 22
Day One Appoints Garry Nicholson as Chairman of the Board of Directors
8:40am
8-K
EX-99.2
a8tta6y mj8r
4 Aug 22
Day One Reports Second Quarter 2022 Financial Results and Corporate Progress
4:53pm
8-K
EX-99.1
31ha r95adw3ww5
24 Jun 22
Submission of Matters to a Vote of Security Holders
4:06pm